Literature DB >> 22425370

The assessment of prognostic factors in surgical treatment of low-grade gliomas: a prospective study.

Krzysztof Majchrzak1, Wojciech Kaspera, Barbara Bobek-Billewicz, Anna Hebda, Gabriela Stasik-Pres, Henryk Majchrzak, Piotr Ładziński.   

Abstract

OBJECTIVE: A prospective volumetric analysis of extent of resection (EOR) was carried out to assess surgical outcomes in adults diagnosed with hemispheric low grade gliomas (LGGs).
MATERIALS AND METHODS: 68 consecutive patients diagnosed with LGGs were enrolled in the study. Pre- and post-operative tumor volumes and EOR were measured based on FLAIR MRI. Dynamic susceptibility contrast perfusion magnetic resonance imaging (DSC MRI) was used for the assessment of relative cerebral blood volume (rCBV). Three outcome measures were assessed: overall survival (OS), progression-free survival (PFS), and malignant degeneration-free survival (MFS).
RESULTS: In 6 (9%) patients permanent neurologic deficits were observed. No statistically significant dependence between the EOR and the occurrence of permanent deficits was found. The eloquent or close to the eloquent location was statistically connected with lower EOR (p=0.023). The preoperative volume of tumors treated with gross total resection was significantly smaller than the volume of tumors in subtotal or partial resection groups (p=0.020, p<0.001, respectively). OS was predicted by age at diagnosis (p=0.032), and rCBV (p=0.002). Progression and malignant transformation occurred in 22 (32%) and 11 (16%) out of 68 patients. PFS was predicted by preoperative tumor volume (p=0.005), postoperative tumor volume (p=0.008), the EOR (p=0.001), and by the rCBV (p=0.033). MFS was predicted by preoperative tumor volume (p=0.034), the EOR (pp=0.020), and by rCBV (p=0.022). Postoperative tumor volume was associated with a trend of improved MFS (p=0.072). The univariate analysis shows the statistical trend for the relationship between histological subtype and PFS and MFS (p=0.079, p=0.078, respectively). Multivariate analysis selected preoperative tumor volume and rCBV as independently associated with PFS (p=0.009, p=0.019, respectively) and MFS (p=0.023, p=0.035, respectively). EOR was associated with a trend of improved PFS, and MFS (p=0.069, p=0.094, respectively).
CONCLUSIONS: Tumor resection of LGG with the use of intraoperative monitoring and neuronavigation is associated with a low risk of new permanent deficits, but EOR significantly decreases with the size of the tumor and/or its location in/close to the eloquent areas. Smaller preoperative tumor volume and greater EOR are significantly associated with longer OS, PFS and MFS. Preoperative rCBV is one of the important prognostic factors significantly connected with survival. Prognosis in LGGs is still under discussion. Other factors such as age, histopathological subtype and KPS should not be underestimated.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22425370     DOI: 10.1016/j.clineuro.2012.02.054

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  25 in total

1.  Comparing high-resolution microscopy techniques for potential intraoperative use in guiding low-grade glioma resections.

Authors:  Daphne Meza; Danni Wang; Yu Wang; Sabine Borwege; Nader Sanai; Jonathan T C Liu
Journal:  Lasers Surg Med       Date:  2015-04-14       Impact factor: 4.025

Review 2.  'Low grade glioma': an update for radiologists.

Authors:  Jennifer Larsen; Steve B Wharton; Fiona McKevitt; Charles Romanowski; Caroline Bridgewater; Hesham Zaki; Nigel Hoggard
Journal:  Br J Radiol       Date:  2016-12-07       Impact factor: 3.039

3.  Predictors and early survival outcomes of maximal resection in WHO grade II 1p/19q-codeleted oligodendrogliomas.

Authors:  Maya Harary; Vasileios K Kavouridis; Matthew Torre; Hasan A Zaidi; Ugonma N Chukwueke; David A Reardon; Timothy R Smith; J Bryan Iorgulescu
Journal:  Neuro Oncol       Date:  2020-03-05       Impact factor: 12.300

4.  Advanced MRI may complement histological diagnosis of lower grade gliomas and help in predicting survival.

Authors:  Valeria Cuccarini; A Erbetta; M Farinotti; L Cuppini; F Ghielmetti; B Pollo; F Di Meco; M Grisoli; G Filippini; G Finocchiaro; M G Bruzzone; M Eoli
Journal:  J Neurooncol       Date:  2016-01       Impact factor: 4.130

Review 5.  Resection of supratentorial gliomas: the need to merge microsurgical technical cornerstones with modern functional mapping concepts. An overview.

Authors:  Giannantonio Spena; Pier Paolo Panciani; Marco Maria Fontanella
Journal:  Neurosurg Rev       Date:  2014-10-21       Impact factor: 3.042

6.  Whole Chromosome 7 Gain Predicts Higher Risk of Recurrence in Pediatric Pilocytic Astrocytomas Independently From KIAA1549-BRAF Fusion Status.

Authors:  Jacquelyn J Roth; Tamara M Fierst; Angela J Waanders; Li Yimei; Jaclyn A Biegel; Mariarita Santi
Journal:  J Neuropathol Exp Neurol       Date:  2016-03-04       Impact factor: 3.685

Review 7.  Li-Fraumeni syndrome: cancer risk assessment and clinical management.

Authors:  Kate A McBride; Mandy L Ballinger; Emma Killick; Judy Kirk; Martin H N Tattersall; Rosalind A Eeles; David M Thomas; Gillian Mitchell
Journal:  Nat Rev Clin Oncol       Date:  2014-03-18       Impact factor: 66.675

8.  Observation after surgery for low grade glioma: long-term outcome in the light of the 2016 WHO classification.

Authors:  Elena Jansen; Christina Hamisch; Daniel Ruess; Dieter Henrik Heiland; Roland Goldbrunner; Maximilian I Ruge; Oliver Schnell; Stefan J Grau
Journal:  J Neurooncol       Date:  2019-10-16       Impact factor: 4.130

9.  Multimodal integrated approaches in low grade glioma surgery.

Authors:  Tamara Ius; Edoardo Mazzucchi; Barbara Tomasino; Giada Pauletto; Giovanni Sabatino; Giuseppe Maria Della Pepa; Giuseppe La Rocca; Claudio Battistella; Alessandro Olivi; Miran Skrap
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

10.  Management of primary thalamic low-grade glioma in pediatric patients: results of the multicenter treatment studies HIT-LGG 1996 and SIOP-LGG 2004.

Authors:  Tineke Boesten; Nicolas U Gerber; Daniela Kandels; Amedeo A Azizi; Rene Schmidt; Monika Warmuth-Metz; Torsten Pietsch; Rolf-Dieter Kortmann; Astrid Gnekow; Michael A Grotzer
Journal:  Neurooncol Pract       Date:  2016-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.